PF-5006739 是一种有效,选择性 CK1δ/ε 抑制剂,IC50 分别为 3.9 nM 和 17.0 nM。 PF-5006739 是一系列精神疾病的潜在治疗剂,具有低纳摩尔的 CK1δ/ε 体外效力和高激酶组选择性。PF-5006739 以剂量依赖的方式减弱动物啮齿动物恢复模型中的阿片类药物寻找行为。PF-5006739 改善了饮食诱导的肥胖 (DIO) 和遗传的 (ob/ob) 小鼠模型中的葡萄糖耐量。
此产品仅用于科学研究,我们不为任何个人用途提供产品和服务
PF-5006739 is a potent and selective inhibitor of CK1δ/ε with IC50s of 3.9 nM and 17.0 nM, respectively. PF-5006739 is a potential therapeutic agent for a range of psychiatric disorders with low nanomolar in vitro potency for CK1δ/ε and high kinome selectivity. PF-5006739 attenuats opioid drug-seeking behavior in a rodent operant reinstatement model in animals in a dose-dependent manner[1]. PF-5006739 improves glucose tolerance in both diet-induced obesity (DIO) and genetic (ob/ob) mice models of obesity[2]. CK1δ|3.9 nM (IC50)|CK1?|17.0 nM (IC50)
[1]. Wager TT, et al. Casein kinase 1δ/ε inhibitor PF-5006739 attenuates opioid drug-seeking behavior. ACS Chem Neurosci. 2014 Dec 17;5(12):1253-65. [2]. Cunningham PS, et al. Targeting of the circadian clock via CK1δ/ε to improve glucose homeostasis in obesity.Sci Rep. 2016 Jul 21;6:29983.
此商品暂时还没有评价哦~